Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$157.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 16 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 20 most recent Form 4 transactions.
| Jun 15 | RXRX | Recursion Pharmaceuticals,… | FTAX | 5,396 | $3.15 | $17K | -0.5% | Open the original filing on SEC.gov |
| May 15 | RXRX | Recursion Pharmaceuticals,… | FTAX | 25,018 | $3.04 | $76.1K | -2.2% | Open the original filing on SEC.gov |
| Apr 6 | RXRX | Recursion Pharmaceuticals,… | FTAX | 48,028 | $3.11 | $149.4K | -4.1% | Open the original filing on SEC.gov |
| Mar 17 | RXRX | Recursion Pharmaceuticals,… | SSELL◷ | 7,956 | $3.39 | $27K | -0.7% | Open the original filing on SEC.gov |
| Mar 16 | RXRX | Recursion Pharmaceuticals,… | FTAX◷ | 7,075 | $3.42 | $24.2K | -0.6% | Open the original filing on SEC.gov |
| Feb 18 | RXRX | Recursion Pharmaceuticals,… | SSELL◷ | 13,426 | $3.08 | $41.4K | -1.1% | Open the original filing on SEC.gov |
| Feb 17 | RXRX | Recursion Pharmaceuticals,… | FTAX◷ | 11,908 | $3.49 | $41.6K | -1.0% | Open the original filing on SEC.gov |
| Feb 6 | RXRX | Recursion Pharmaceuticals,… | FTAX | 11,400 | $3.98 | $45.4K | -0.9% | Open the original filing on SEC.gov |
| Feb 6 | RXRX | Recursion Pharmaceuticals,… | AGRANT | 24,254 | — | — | +2.0% | Open the original filing on SEC.gov |
| Feb 6 | RXRX | Recursion Pharmaceuticals,… | AGRANT | 446,279 | — | — | +58.6% | Open the original filing on SEC.gov |
| Dec 29, 2025 | RXRX | Recursion Pharmaceuticals,… | SSELL◷ | 21,383 | $4.18 | $89.4K | -2.7% | Open the original filing on SEC.gov |
| Dec 15, 2025 | RXRX | Recursion Pharmaceuticals,… | FTAX | 7,057 | $4.33 | $30.6K | -0.9% | Open the original filing on SEC.gov |
| Nov 25, 2025 | RXRX | Recursion Pharmaceuticals,… | FTAX | 2,271 | $4.03 | $9.2K | -0.3% | Open the original filing on SEC.gov |
| Nov 17, 2025 | RXRX | Recursion Pharmaceuticals,… | FTAX | 11,908 | $4.14 | $49.3K | -1.5% | Open the original filing on SEC.gov |
| Sep 15, 2025 | RXRX | Recursion Pharmaceuticals,… | FTAX | 7,057 | $4.83 | $34.1K | -0.9% | Open the original filing on SEC.gov |
| Aug 15, 2025 | RXRX | Recursion Pharmaceuticals,… | FTAX | 11,908 | $5.64 | $67.2K | -1.5% | Open the original filing on SEC.gov |
| Jun 16, 2025 | RXRX | Recursion Pharmaceuticals,… | FTAX | 7,057 | $4.92 | $34.7K | -0.9% | Open the original filing on SEC.gov |
| May 15, 2025 | RXRX | Recursion Pharmaceuticals,… | FTAX | 11,908 | $4.25 | $50.6K | -1.4% | Open the original filing on SEC.gov |